MedPath

An explorative study of the oral language production difficulties in Arabic speaking aphasia patients in the Netherlands.

Recruiting
Conditions
Aphasia after CVA
language problems after a stroke
10007963
Registration Number
NL-OMON35165
Lead Sponsor
Slotervaartziekenhuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

CVA in the left hemisphere, with a mild aphasia as a result.
Right handed
The mother tongue is (Maroccan) Arabic.
The language used at home is Arabic.

Exclusion Criteria

The existence of severe hearing problems or other problems (non-related to the aphasia) that hinder the communication.
The premorbid existence of language disorders.
The premorbid existence of neurological disorders.
The existence of an CVA in the right hemisphere.
The aphasia ia so severe that communication on (short) sentence level is impossible.
The existence of a severe dysarthria or verbal apraxia, thus rendering the language sample non-transcribable.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The difference between the test group and the control group will be based on<br /><br>the following linguistic measures of the ASTA:<br /><br>- The amount of: nouns, lexical verbs, repetitions, minimal responses,<br /><br>neologisms, echolalia, stereotypes, semantic and syntactic paraphasias.<br /><br>- The diversity (type-token ratio) of: nouns and lexical verbs.<br /><br>- The mean length of utterance (MLU)<br /><br>- The percentage of correct utterances.<br /><br>- The finiteness index<br /><br>- The amount of clauses.<br /><br><br /><br>In addition, while analysing the language samples, special attention will be<br /><br>paid to measures specific for the Arabic language, which may differ<br /><br>significantly between the two test groups.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>N.A.</p><br>
© Copyright 2025. All Rights Reserved by MedPath